2026 Pediatric Endocrinology Symposium Evaluation

1 Start 2 Complete

Please take a moment to provide feedback about the 2026 George A. Burghen Human Growth Foundation Pediatric Endocrine Symposium. This valuable information will help planners and organizers in the planning of future meetings.

Course Objectives *

Please rate how well course objectives were met for this activity.

	Excellent	Good	Average	Below Average	Poor	N/A
Identify risk factors and describe treatment options for early-onset obesity in children.	Identify risk factors and describe treatment options for early-onset obesity in children. - Excellent	Identify risk factors and describe treatment options for early-onset obesity in children. - Good	Identify risk factors and describe treatment options for early-onset obesity in children. - Average	Identify risk factors and describe treatment options for early-onset obesity in children. - Below Average	Identify risk factors and describe treatment options for early-onset obesity in children. - Poor	Identify risk factors and describe treatment options for early-onset obesity in children. - N/A
Describe the indications for and the risks and benefits of bariatric surgery among pediatric patients.	Describe the indications for and the risks and benefits of bariatric surgery among pediatric patients. - Excellent	Describe the indications for and the risks and benefits of bariatric surgery among pediatric patients. - Good	Describe the indications for and the risks and benefits of bariatric surgery among pediatric patients. - Average	Describe the indications for and the risks and benefits of bariatric surgery among pediatric patients. - Below Average	Describe the indications for and the risks and benefits of bariatric surgery among pediatric patients. - Poor	Describe the indications for and the risks and benefits of bariatric surgery among pediatric patients. - N/A
Explain that type 1 diabetes is a chronic autoimmune disease that can be detected long before a patient develops hyperglycemia, and describe interventions to delay onset of clinical diabetes.	Explain that type 1 diabetes is a chronic autoimmune disease that can be detected long before a patient develops hyperglycemia, and describe interventions to delay onset of clinical diabetes. - Excellent	Explain that type 1 diabetes is a chronic autoimmune disease that can be detected long before a patient develops hyperglycemia, and describe interventions to delay onset of clinical diabetes. - Good	Explain that type 1 diabetes is a chronic autoimmune disease that can be detected long before a patient develops hyperglycemia, and describe interventions to delay onset of clinical diabetes. - Average	Explain that type 1 diabetes is a chronic autoimmune disease that can be detected long before a patient develops hyperglycemia, and describe interventions to delay onset of clinical diabetes. - Below Average	Explain that type 1 diabetes is a chronic autoimmune disease that can be detected long before a patient develops hyperglycemia, and describe interventions to delay onset of clinical diabetes. - Poor	Explain that type 1 diabetes is a chronic autoimmune disease that can be detected long before a patient develops hyperglycemia, and describe interventions to delay onset of clinical diabetes. - N/A
Differentiate exogenous obesity from hypercortisolism in children.	Differentiate exogenous obesity from hypercortisolism in children. - Excellent	Differentiate exogenous obesity from hypercortisolism in children. - Good	Differentiate exogenous obesity from hypercortisolism in children. - Average	Differentiate exogenous obesity from hypercortisolism in children. - Below Average	Differentiate exogenous obesity from hypercortisolism in children. - Poor	Differentiate exogenous obesity from hypercortisolism in children. - N/A
Describe the pathophysiology and management of pediatric calcium disorders.	Describe the pathophysiology and management of pediatric calcium disorders. - Excellent	Describe the pathophysiology and management of pediatric calcium disorders. - Good	Describe the pathophysiology and management of pediatric calcium disorders. - Average	Describe the pathophysiology and management of pediatric calcium disorders. - Below Average	Describe the pathophysiology and management of pediatric calcium disorders. - Poor	Describe the pathophysiology and management of pediatric calcium disorders. - N/A

Give one or two examples of patient outcomes that will be directly impacted as a result of participating in this activity. *

What specific changes will you make in your practice/clinical care because of participating in this activity? *

Was the material presented in a manner that was free from commercial bias? *

Yes

No - List commercial bias:

Was the material presented in a manner that was free from commercial bias? No - List commercial bias:

Please provide any additional comments regarding any of the speakers’ content / presentations or suggestions for future topics for this conference.

Leave this field blank

You are here

2026 Pediatric Endocrinology Symposium Evaluation